Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBriefing
The government released 2027 Medicare Advantage quality ratings, and early coverage singled out Humana as the …
The WeekPharmaceutical Technology ↗
Perceptive Discovery and Nucleus RadioPharma have announced a non-exclusive strategic partnership to assist ra…
The WeekAJMC ↗
Using Complement Inhibitors in GA Comes With Pros and Cons…
The WeekBriefing
Caribou is exploring strategic alternatives, according to BioPharma Dive’s summary. That alone is enough to pu…
The WeekAJMC ↗
Closing the Gaps in Ocular Emergency Care: James D. Auran, MD…
The WeekSTAT News ↗
Just 40 percent of Americans reported a lot of confidence in U.S. hospitals and health clinics, the same propo…
The WeekBriefing
KFF’s latest Medicare explainer lays out the annual Oct. 15 to Dec. 7 enrollment window and the coverage chang…
The WeekAJMC ↗
Multi-Hit TP53 Linked to Shorter Survival in Chronic-Phase MPN Cohorts…
The WeekSTAT News ↗
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being consi…
The WeekSTAT News ↗
The AHA is once again suing the Trump administration over its plan to revamp a federal drug discount program i…
The WeekBioPharma Dive ↗
The new disclosure suggested Rasonque might not be as broadly effective as previously thought. Elsewhere, Ultr…
The WeekPharmaceutical Technology ↗
A US listing for the oncology specialist continues a bumper year for biotech IPOs.…
The WeekKFF Health News ↗
This brief provides background on Title VI, summarizes the key changes in the 2026 final rule, and discusses t…
The WeekBioPharma Dive ↗
The latest installment in BioPharma Dive's data visualization series features a look at the factors pressuring…
The WeekPharmaVoice ↗
HHS is cranking up its efforts to accelerate drug development; more reports are emerging about off target effe…
The WeekPharmaVoice ↗
Dr. Eliav Barr pulls back the curtain on what it's like to manage Merck's fast-growing pipeline.…
The WeekKFF Health News ↗
The analysis shows that plan level Medicare Advantage prescription drug availability varies widely across the …
The WeekBioPharma Dive ↗
Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions …
The WeekPharmaceutical Technology ↗
Tecentriq is now the first immunotherapy indicated for dMMR colon cancer specifically, which is often linked t…
The WeekBriefing
An HHS leader’s new public framing of 340B points to a reform effort aimed at program design, not just adminis…
The WeekDrug Channels ↗
Today's guest post comes from Meghal Patel, Chief Product Officer for Truzo at Model N. Meghal examines why cl…
The WeekSTAT News ↗
As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling…
The WeekPharmaceutical Technology ↗
Biohaven has entered into an exclusive regional collaboration and licensing agreement worth up to $100m with O…
The WeekAJMC ↗
Global Heart Failure Cases More Than Doubled to 56 Million Since 1990…
Page 1
Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.